Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE)

• Main Authors: Dickhaut K., Hoepner S., Eckhard J., Wiesmueller K.-H., Schindler L., Jung G., Falk K., Roetzschke O.
• Other Authors: MICROBIOLOGY AND IMMUNOLOGY
• Format: Article
• Published: 2019
• Subjects: adamantane; HLA DR antigen; HLA DR1 antigen; HLA DR4 antigen; major histocompatibility antigen; major histocompatibility antigen class 2; NY ESO 1 antigen; tumor antigen; cancer vaccine; HLA antigen class 2; subunit vaccine; animal cell; animal experiment; animal model; antibody combining site; antigen presenting cell; article; catalysis; CD4+ T lymphocyte; controlled study; dendritic cell; immune response; in vivo study; Influenza virus; ligand binding; mouse; nonhuman; transgenic mouse; animal; Bagg albino mouse; cell proliferation; cell separation; chemistry; CpG island; human; immunology; immunotherapy; methodology; neoplasm; tumor cell line; Murinae; Mus; Orthomyxoviridae; Animals; Cancer Vaccines; CD4-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Cell Separation; CpG Islands; Histocompatibility Antigens Class II; Humans; Immunotherapy; Mice; Mice, Inbred BALB C; Mice, Transgenic; Neoplasms; Vaccines, Subunit
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/161829
• Institution: National University of Singapore

10.1371/journal.pone.0006811